New Zealand - English - Medsafe (Medicines Safety Authority)

max health limited - voriconazole 200mg - powder for infusion - 200 mg - active: voriconazole 200mg excipient: hydrochloric acid hydroxypropyl-beta-cyclodextrin sodium chloride - voriconazole is indicated for treatment of the following fungal infections: · invasive aspergillosis. · serious candida infections (including c. krusei), including oesophageal and systemic candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia). · serious fungal infections caused by scedosporium spp. and fusarium spp. · other serious fungal infections, in patients intolerant of, or refractory to, other therapy.

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

fourrts (india) laboratories private limited, india - ibuprofen tablets bp 200 mg - tablets - 200

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

unique pharmaceutical laboratories (a division of j.b. chemicals & pharmaceuticals ltd), india - metronidazole bp - tablets - 200

United States - English - NLM (National Library of Medicine)

emergent product development gaithersburg inc. - vaccinia virus strain new york city board of health live antigen (unii: 4sv59689sk) (vaccinia virus strain new york city board of health live antigen - unii:4sv59689sk) - acam2000® is indicated for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection. there are very few absolute contraindications to this vaccine for those who are at high risk for smallpox. the risk for experiencing serious vaccination complications must be weighed against the risks for experiencing a potentially fatal smallpox infection. see warnings and precautions (5) for persons who are at higher risk of experiencing serious vaccination complications. severe immune deficiency severe localized or systemic infection with vaccinia (progressive vaccinia) may occur in persons with weakened immune systems. individuals with severe immunodeficiency who are not expected to benefit from the vaccine should not receive acam2000. these individuals may include individuals who are undergoing bone marrow transplantation or individuals with primary or acquired immunodeficiency who require isolation. acam2000 has not been studied in pregnant women. live vaccini

United States - English - NLM (National Library of Medicine)

strategic sourcing services llc - miconazole nitrate (200 mg in each suppository), miconazole nitrate 2% (external cream) - vaginal antifungal

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

al ittihad drug store france - 200 ml vial - infusion - 10 g/ 200ml - immunologicals , vaccines-immunoglobulins

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

alphamed drug store jordan - 200 ml bag - infusion - 400 mg/200 ml - infections-antibacterial

Australia - English - Department of Health (Therapeutic Goods Administration)

ms health pty ltd - misoprostol, quantity: 200 microgram - tablet - excipient ingredients: hypromellose; microcrystalline cellulose; sodium starch glycollate; hydrogenated castor oil - gymiso is indicated in females of childbearing age for the medical termination of a developing intrauterine pregnancy in sequential combination with a mifepristone 200 mg tablet, up to 49 days of gestation.

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - dacarbazine, quantity: 200 mg - injection, powder for - excipient ingredients: citric acid monohydrate; mannitol; sodium hydroxide - dacarbazine is indicated for the treatment of patients with metastatic malignant melanoma. dacarbazine is used as part of combination chemotherapy for the treatment of advanced hodgkin's disease, advanced adult soft tissue sarcomas (except mesothelioma and kaposi sarcoma). dacarbazine has been shown, when used in combination with other cytotoxic agents, to be of use in the treatment of other malignant diseases including carcinoma of the colon, ovary, breast, lung, testicular teratoma, and solid tumours in children.

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - amisulpride 200mg;  ;   - tablet - 200 mg - active: amisulpride 200mg     excipient: hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate